The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermatology OTC Medications Market Research Report 2024
Synopsis
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
The global Dermatology OTC Medications market was valued at US$ 12780 million in 2023 and is anticipated to reach US$ 16080 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Dermatology OTC Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology OTC Medications.
Report Scope
The Dermatology OTC Medications market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology OTC Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatology OTC Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Segment by Type
External Use
Oral
Segment by Application
Hospital
Drug Store
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dermatology OTC Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dermatology OTC Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
The global Dermatology OTC Medications market was valued at US$ 12780 million in 2023 and is anticipated to reach US$ 16080 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
This report aims to provide a comprehensive presentation of the global market for Dermatology OTC Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatology OTC Medications.
Report Scope
The Dermatology OTC Medications market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatology OTC Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatology OTC Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Segment by Type
External Use
Oral
Segment by Application
Hospital
Drug Store
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dermatology OTC Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dermatology OTC Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dermatology OTC Medications Market Overview
1.1 Product Overview and Scope of Dermatology OTC Medications
1.2 Dermatology OTC Medications Segment by Type
1.2.1 Global Dermatology OTC Medications Market Value Comparison by Type (2024-2030)
1.2.2 External Use
1.2.3 Oral
1.3 Dermatology OTC Medications Segment by Application
1.3.1 Global Dermatology OTC Medications Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Global Dermatology OTC Medications Market Size Estimates and Forecasts
1.4.1 Global Dermatology OTC Medications Revenue 2019-2030
1.4.2 Global Dermatology OTC Medications Sales 2019-2030
1.4.3 Global Dermatology OTC Medications Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dermatology OTC Medications Market Competition by Manufacturers
2.1 Global Dermatology OTC Medications Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dermatology OTC Medications Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dermatology OTC Medications Average Price by Manufacturers (2019-2024)
2.4 Global Dermatology OTC Medications Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dermatology OTC Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dermatology OTC Medications, Product Type & Application
2.7 Dermatology OTC Medications Market Competitive Situation and Trends
2.7.1 Dermatology OTC Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dermatology OTC Medications Players Market Share by Revenue
2.7.3 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dermatology OTC Medications Retrospective Market Scenario by Region
3.1 Global Dermatology OTC Medications Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dermatology OTC Medications Global Dermatology OTC Medications Sales by Region: 2019-2030
3.2.1 Global Dermatology OTC Medications Sales by Region: 2019-2024
3.2.2 Global Dermatology OTC Medications Sales by Region: 2025-2030
3.3 Global Dermatology OTC Medications Global Dermatology OTC Medications Revenue by Region: 2019-2030
3.3.1 Global Dermatology OTC Medications Revenue by Region: 2019-2024
3.3.2 Global Dermatology OTC Medications Revenue by Region: 2025-2030
3.4 North America Dermatology OTC Medications Market Facts & Figures by Country
3.4.1 North America Dermatology OTC Medications Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dermatology OTC Medications Sales by Country (2019-2030)
3.4.3 North America Dermatology OTC Medications Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dermatology OTC Medications Market Facts & Figures by Country
3.5.1 Europe Dermatology OTC Medications Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dermatology OTC Medications Sales by Country (2019-2030)
3.5.3 Europe Dermatology OTC Medications Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dermatology OTC Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Dermatology OTC Medications Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dermatology OTC Medications Sales by Country (2019-2030)
3.6.3 Asia Pacific Dermatology OTC Medications Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dermatology OTC Medications Market Facts & Figures by Country
3.7.1 Latin America Dermatology OTC Medications Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dermatology OTC Medications Sales by Country (2019-2030)
3.7.3 Latin America Dermatology OTC Medications Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dermatology OTC Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Dermatology OTC Medications Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dermatology OTC Medications Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dermatology OTC Medications Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dermatology OTC Medications Sales by Type (2019-2030)
4.1.1 Global Dermatology OTC Medications Sales by Type (2019-2024)
4.1.2 Global Dermatology OTC Medications Sales by Type (2025-2030)
4.1.3 Global Dermatology OTC Medications Sales Market Share by Type (2019-2030)
4.2 Global Dermatology OTC Medications Revenue by Type (2019-2030)
4.2.1 Global Dermatology OTC Medications Revenue by Type (2019-2024)
4.2.2 Global Dermatology OTC Medications Revenue by Type (2025-2030)
4.2.3 Global Dermatology OTC Medications Revenue Market Share by Type (2019-2030)
4.3 Global Dermatology OTC Medications Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dermatology OTC Medications Sales by Application (2019-2030)
5.1.1 Global Dermatology OTC Medications Sales by Application (2019-2024)
5.1.2 Global Dermatology OTC Medications Sales by Application (2025-2030)
5.1.3 Global Dermatology OTC Medications Sales Market Share by Application (2019-2030)
5.2 Global Dermatology OTC Medications Revenue by Application (2019-2030)
5.2.1 Global Dermatology OTC Medications Revenue by Application (2019-2024)
5.2.2 Global Dermatology OTC Medications Revenue by Application (2025-2030)
5.2.3 Global Dermatology OTC Medications Revenue Market Share by Application (2019-2030)
5.3 Global Dermatology OTC Medications Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Dermatology OTC Medications Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Dermatology OTC Medications Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Dermatology OTC Medications Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Dermatology OTC Medications Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Dermatology OTC Medications Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Dermatology OTC Medications Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Dermatology OTC Medications Product Portfolio
6.7.5 Sun Pharmaceutical Recent Developments/Updates
6.8 Aurobindo
6.8.1 Aurobindo Corporation Information
6.8.2 Aurobindo Description and Business Overview
6.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aurobindo Dermatology OTC Medications Product Portfolio
6.8.5 Aurobindo Recent Developments/Updates
6.9 Galderma
6.9.1 Galderma Corporation Information
6.9.2 Galderma Description and Business Overview
6.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Galderma Dermatology OTC Medications Product Portfolio
6.9.5 Galderma Recent Developments/Updates
6.10 CR SANJIU
6.10.1 CR SANJIU Corporation Information
6.10.2 CR SANJIU Description and Business Overview
6.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CR SANJIU Dermatology OTC Medications Product Portfolio
6.10.5 CR SANJIU Recent Developments/Updates
6.11 Dr. Reddy's
6.11.1 Dr. Reddy's Corporation Information
6.11.2 Dr. Reddy's Dermatology OTC Medications Description and Business Overview
6.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Dr. Reddy's Dermatology OTC Medications Product Portfolio
6.11.5 Dr. Reddy's Recent Developments/Updates
6.12 Lupin
6.12.1 Lupin Corporation Information
6.12.2 Lupin Dermatology OTC Medications Description and Business Overview
6.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Lupin Dermatology OTC Medications Product Portfolio
6.12.5 Lupin Recent Developments/Updates
6.13 Bausch Health
6.13.1 Bausch Health Corporation Information
6.13.2 Bausch Health Dermatology OTC Medications Description and Business Overview
6.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Bausch Health Dermatology OTC Medications Product Portfolio
6.13.5 Bausch Health Recent Developments/Updates
6.14 Cipla
6.14.1 Cipla Corporation Information
6.14.2 Cipla Dermatology OTC Medications Description and Business Overview
6.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cipla Dermatology OTC Medications Product Portfolio
6.14.5 Cipla Recent Developments/Updates
6.15 Qilu Pharmaceutical
6.15.1 Qilu Pharmaceutical Corporation Information
6.15.2 Qilu Pharmaceutical Dermatology OTC Medications Description and Business Overview
6.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Qilu Pharmaceutical Dermatology OTC Medications Product Portfolio
6.15.5 Qilu Pharmaceutical Recent Developments/Updates
6.16 Almirall
6.16.1 Almirall Corporation Information
6.16.2 Almirall Dermatology OTC Medications Description and Business Overview
6.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Almirall Dermatology OTC Medications Product Portfolio
6.16.5 Almirall Recent Developments/Updates
6.17 Lingrui
6.17.1 Lingrui Corporation Information
6.17.2 Lingrui Dermatology OTC Medications Description and Business Overview
6.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Lingrui Dermatology OTC Medications Product Portfolio
6.17.5 Lingrui Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dermatology OTC Medications Industry Chain Analysis
7.2 Dermatology OTC Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dermatology OTC Medications Production Mode & Process
7.4 Dermatology OTC Medications Sales and Marketing
7.4.1 Dermatology OTC Medications Sales Channels
7.4.2 Dermatology OTC Medications Distributors
7.5 Dermatology OTC Medications Customers
8 Dermatology OTC Medications Market Dynamics
8.1 Dermatology OTC Medications Industry Trends
8.2 Dermatology OTC Medications Market Drivers
8.3 Dermatology OTC Medications Market Challenges
8.4 Dermatology OTC Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dermatology OTC Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Dermatology OTC Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Dermatology OTC Medications Market Competitive Situation by Manufacturers in 2023
Table 4. Global Dermatology OTC Medications Sales (M Units) of Key Manufacturers (2019-2024)
Table 5. Global Dermatology OTC Medications Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Dermatology OTC Medications Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Dermatology OTC Medications Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Dermatology OTC Medications Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Dermatology OTC Medications, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dermatology OTC Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dermatology OTC Medications, Product Type & Application
Table 12. Global Key Manufacturers of Dermatology OTC Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatology OTC Medications as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dermatology OTC Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Dermatology OTC Medications Sales by Region (2019-2024) & (M Units)
Table 18. Global Dermatology OTC Medications Sales Market Share by Region (2019-2024)
Table 19. Global Dermatology OTC Medications Sales by Region (2025-2030) & (M Units)
Table 20. Global Dermatology OTC Medications Sales Market Share by Region (2025-2030)
Table 21. Global Dermatology OTC Medications Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Dermatology OTC Medications Revenue Market Share by Region (2019-2024)
Table 23. Global Dermatology OTC Medications Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Dermatology OTC Medications Revenue Market Share by Region (2025-2030)
Table 25. North America Dermatology OTC Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Dermatology OTC Medications Sales by Country (2019-2024) & (M Units)
Table 27. North America Dermatology OTC Medications Sales by Country (2025-2030) & (M Units)
Table 28. North America Dermatology OTC Medications Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Dermatology OTC Medications Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Dermatology OTC Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Dermatology OTC Medications Sales by Country (2019-2024) & (M Units)
Table 32. Europe Dermatology OTC Medications Sales by Country (2025-2030) & (M Units)
Table 33. Europe Dermatology OTC Medications Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Dermatology OTC Medications Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Dermatology OTC Medications Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Dermatology OTC Medications Sales by Region (2019-2024) & (M Units)
Table 37. Asia Pacific Dermatology OTC Medications Sales by Region (2025-2030) & (M Units)
Table 38. Asia Pacific Dermatology OTC Medications Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Dermatology OTC Medications Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Dermatology OTC Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Dermatology OTC Medications Sales by Country (2019-2024) & (M Units)
Table 42. Latin America Dermatology OTC Medications Sales by Country (2025-2030) & (M Units)
Table 43. Latin America Dermatology OTC Medications Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Dermatology OTC Medications Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Dermatology OTC Medications Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Dermatology OTC Medications Sales by Country (2019-2024) & (M Units)
Table 47. Middle East & Africa Dermatology OTC Medications Sales by Country (2025-2030) & (M Units)
Table 48. Middle East & Africa Dermatology OTC Medications Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Dermatology OTC Medications Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Dermatology OTC Medications Sales (M Units) by Type (2019-2024)
Table 51. Global Dermatology OTC Medications Sales (M Units) by Type (2025-2030)
Table 52. Global Dermatology OTC Medications Sales Market Share by Type (2019-2024)
Table 53. Global Dermatology OTC Medications Sales Market Share by Type (2025-2030)
Table 54. Global Dermatology OTC Medications Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Dermatology OTC Medications Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Dermatology OTC Medications Revenue Market Share by Type (2019-2024)
Table 57. Global Dermatology OTC Medications Revenue Market Share by Type (2025-2030)
Table 58. Global Dermatology OTC Medications Price (USD/Unit) by Type (2019-2024)
Table 59. Global Dermatology OTC Medications Price (USD/Unit) by Type (2025-2030)
Table 60. Global Dermatology OTC Medications Sales (M Units) by Application (2019-2024)
Table 61. Global Dermatology OTC Medications Sales (M Units) by Application (2025-2030)
Table 62. Global Dermatology OTC Medications Sales Market Share by Application (2019-2024)
Table 63. Global Dermatology OTC Medications Sales Market Share by Application (2025-2030)
Table 64. Global Dermatology OTC Medications Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Dermatology OTC Medications Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Dermatology OTC Medications Revenue Market Share by Application (2019-2024)
Table 67. Global Dermatology OTC Medications Revenue Market Share by Application (2025-2030)
Table 68. Global Dermatology OTC Medications Price (USD/Unit) by Application (2019-2024)
Table 69. Global Dermatology OTC Medications Price (USD/Unit) by Application (2025-2030)
Table 70. Bayer Corporation Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bayer Dermatology OTC Medications Product
Table 74. Bayer Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK Dermatology OTC Medications Product
Table 79. GSK Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Teva Dermatology OTC Medications Product
Table 84. Teva Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson Dermatology OTC Medications Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Novartis Dermatology OTC Medications Product
Table 94. Novartis Recent Developments/Updates
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Mylan Dermatology OTC Medications Product
Table 99. Mylan Recent Developments/Updates
Table 100. Sun Pharmaceutical Corporation Information
Table 101. Sun Pharmaceutical Description and Business Overview
Table 102. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Sun Pharmaceutical Dermatology OTC Medications Product
Table 104. Sun Pharmaceutical Recent Developments/Updates
Table 105. Aurobindo Corporation Information
Table 106. Aurobindo Description and Business Overview
Table 107. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Aurobindo Dermatology OTC Medications Product
Table 109. Aurobindo Recent Developments/Updates
Table 110. Galderma Corporation Information
Table 111. Galderma Description and Business Overview
Table 112. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Galderma Dermatology OTC Medications Product
Table 114. Galderma Recent Developments/Updates
Table 115. CR SANJIU Corporation Information
Table 116. CR SANJIU Description and Business Overview
Table 117. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. CR SANJIU Dermatology OTC Medications Product
Table 119. CR SANJIU Recent Developments/Updates
Table 120. Dr. Reddy's Corporation Information
Table 121. Dr. Reddy's Description and Business Overview
Table 122. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Dr. Reddy's Dermatology OTC Medications Product
Table 124. Dr. Reddy's Recent Developments/Updates
Table 125. Lupin Corporation Information
Table 126. Lupin Description and Business Overview
Table 127. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Lupin Dermatology OTC Medications Product
Table 129. Lupin Recent Developments/Updates
Table 130. Bausch Health Corporation Information
Table 131. Bausch Health Description and Business Overview
Table 132. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Bausch Health Dermatology OTC Medications Product
Table 134. Bausch Health Recent Developments/Updates
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Cipla Dermatology OTC Medications Product
Table 139. Cipla Recent Developments/Updates
Table 140. Qilu Pharmaceutical Corporation Information
Table 141. Qilu Pharmaceutical Description and Business Overview
Table 142. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Qilu Pharmaceutical Dermatology OTC Medications Product
Table 144. Qilu Pharmaceutical Recent Developments/Updates
Table 145. Almirall Corporation Information
Table 146. Almirall Description and Business Overview
Table 147. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Almirall Dermatology OTC Medications Product
Table 149. Almirall Recent Developments/Updates
Table 150. Lingrui Corporation Information
Table 151. Lingrui Description and Business Overview
Table 152. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Lingrui Dermatology OTC Medications Product
Table 154. Lingrui Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Dermatology OTC Medications Distributors List
Table 158. Dermatology OTC Medications Customers List
Table 159. Dermatology OTC Medications Market Trends
Table 160. Dermatology OTC Medications Market Drivers
Table 161. Dermatology OTC Medications Market Challenges
Table 162. Dermatology OTC Medications Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dermatology OTC Medications
Figure 2. Global Dermatology OTC Medications Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Dermatology OTC Medications Market Share by Type in 2023 & 2030
Figure 4. External Use Product Picture
Figure 5. Oral Product Picture
Figure 6. Global Dermatology OTC Medications Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Dermatology OTC Medications Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Other
Figure 11. Global Dermatology OTC Medications Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Dermatology OTC Medications Market Size (2019-2030) & (US$ Million)
Figure 13. Global Dermatology OTC Medications Sales (2019-2030) & (M Units)
Figure 14. Global Dermatology OTC Medications Average Price (USD/Unit) & (2019-2030)
Figure 15. Dermatology OTC Medications Report Years Considered
Figure 16. Dermatology OTC Medications Sales Share by Manufacturers in 2023
Figure 17. Global Dermatology OTC Medications Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Dermatology OTC Medications Players: Market Share by Revenue in 2023
Figure 19. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Dermatology OTC Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Dermatology OTC Medications Sales Market Share by Country (2019-2030)
Figure 22. North America Dermatology OTC Medications Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Dermatology OTC Medications Sales Market Share by Country (2019-2030)
Figure 26. Europe Dermatology OTC Medications Revenue Market Share by Country (2019-2030)
Figure 27. Germany Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Dermatology OTC Medications Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Dermatology OTC Medications Revenue Market Share by Region (2019-2030)
Figure 34. China Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Dermatology OTC Medications Sales Market Share by Country (2019-2030)
Figure 45. Latin America Dermatology OTC Medications Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Dermatology OTC Medications Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Dermatology OTC Medications Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Dermatology OTC Medications Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Dermatology OTC Medications by Type (2019-2030)
Figure 55. Global Revenue Market Share of Dermatology OTC Medications by Type (2019-2030)
Figure 56. Global Dermatology OTC Medications Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Dermatology OTC Medications by Application (2019-2030)
Figure 58. Global Revenue Market Share of Dermatology OTC Medications by Application (2019-2030)
Figure 59. Global Dermatology OTC Medications Price (USD/Unit) by Application (2019-2030)
Figure 60. Dermatology OTC Medications Value Chain
Figure 61. Dermatology OTC Medications Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
